INNATE PHARMA

The current price of IPH is 2.20 EUR — it has decreased by 2.65% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange INNATE PHARMA stocks are traded under the ticker IPH.

INNATE PHARMA is going to release the next earnings report on Sep 12, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for INNATE PHARMA has a max estimate of 10.70 EUR and a min estimate of 2.25 EUR.

IPH earnings for the last quarter are 0.02 EUR whereas the estimation was 0.08 EUR which accounts for −75.00% surprise. Estimated earnings for the next quarter are −0.40 EUR. See more details about INNATE PHARMA earnings.

Yes, you can track INNATE PHARMA financials in yearly and quarterly reports right on TradingView.

Like other stocks, IPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNATE PHARMA stock right from TradingView charts — choose your broker and connect to your account.

IPH reached its all-time high on Apr 27, 2015 with the price of 17.85 EUR, and its all-time low was 1.05 EUR and was reached on Oct 10, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 179.00 employees. See our rating of the largest employees — is INNATE PHARMA on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNATE PHARMA EBITDA is ‪−17.32 M‬ EUR, and current EBITDA margin is −33.36%. See more stats in INNATE PHARMA financial statements.